Metformin, Statins May Reduce Hepatocellular Carcinoma Risk After HCV Treatment Failure
Findings from a recent study are providing insight into the potential protective effect of metformin and statins for reducing hepatocellular carcinoma (HCC) risk among patients with chronic hepatitis C virus (HCV) who fail antiviral therapy.1 Study results …